Nephrocare Wins Relief as Uzbekistan Court Invalidates ₹14.79 Crore Tax Demand
Nephrocare Health Services Ltd · Others (Uncategorized) · 03 Nov 2026, 3:48 am
Nephrocare Wins Relief as Uzbekistan Court Invalidates ₹14.79 Crore Tax Demand The Tashkent Inter-District Administrative Court in Uzbekistan ruled in favor of Nephrocare Health Services Limited's wholly-owned subsidiary, Nephrocare Health Services Central Asia LLC, declaring a ₹14.79 crore (UZS 18.27 billion) tax and penalty demand invalid. The assessment, covering Jan'23 to Dec'25, was quashed due to procedural irregularities. The court directed the Tashkent City Tax Department to reconsider the audit within 30 days of the order entering into force, stipulating that any reassessment cannot worsen the subsidiary's financial position relative to the invalidated decision.
Original exchange filing (PDF)
More announcements from Nephrocare Health Services Ltd
- We hereby inform that the Company has approved grant of ESOPs under the Scheme as per the disclosure annexed herewith. · 17 Nov 2026
- Pursuant to Reg 30 of SEBI Listing Regulations, 2015, we hereby inform that the Company has approved allotment of 3,42,130 equity shares of Rs. 2/- each, pursuant to the exercise of stock .... · 17 Nov 2026
- Please find enclosed herewith Transcripts for the Investors Earnings call held on November 4, 2026. · 12 Nov 2026
- Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith. · 12 Nov 2026
- In Continuation to our letter dated October 21, 2026 please find enclosed link of the audio recording of the Investors'' Conference Call held on November 04, 2026 on the Unaudited Standalone .... · 04 Nov 2026
- Please find attached monitoring agency report for the quarter ended September 30, 2026. · 04 Nov 2026
- Please find investor presentation for quarter and half year ended September 30, 2026. · 03 Nov 2026
- Press release on Unaudited standalone and consolidated financial results for quarter and half year ended September 30, 2026. · 03 Nov 2026
